10-K: U.S. Physical Therapy Reports Fiscal Year 2024 Results, Announces Dividend Increase and New Acquisition

U.S. Physical Therapy, Inc. announces its financial results for the year ended December 31, 2024, highlighting revenue growth, strategic acquisitions, and an increased dividend.

Summary

• U.S. Physical Therapy, Inc. reported a net revenue increase of 11.0% to $671.3 million for the year ended December 31, 2024, compared to $604.8 million in 2023.
• Operating costs increased by 13.3% to $547.4 million, primarily due to new clinic additions.
• The company closed 45 underperforming clinics, incurring $4.4 million in closure costs.
• U.S. Physical Therapy's net income was $31.4 million for 2024, compared to $28.2 million in 2023.
• Earnings per share were $1.84 for 2024, compared to $1.28 in 2023.
• The company completed several acquisitions, including a 75% interest in an eight-clinic physical therapy practice and a 50% interest in MSO Metro, LLC.
• The Board of Directors raised the quarterly dividend rate from $0.44 to $0.45 per share.
• The company acquired a 65% interest in a physical therapy practice with three clinic locations on February 28, 2025.
• Medicare reimbursement rates are expected to decrease by approximately 2.9% in 2025.

Sentiment

Score: 7

Explanation: The document presents a mixed picture with positive revenue growth and strategic acquisitions, but also highlights increasing costs and regulatory challenges. The dividend increase is a positive signal, but the expected decrease in Medicare reimbursement is a concern.

Positives

• Net revenue increased by 11.0% to $671.3 million.
• Adjusted EBITDA increased to $81.8 million.
• The Board of Directors increased the quarterly dividend rate.
• The company completed several strategic acquisitions.
• The company managed 39 hospital and/or physician owned physical therapy practices as of December 31, 2024, through management contracts.

Negatives

• Operating costs increased by 13.3% to $547.4 million.
• The company closed 45 underperforming clinics, incurring $4.4 million in closure costs.
• A non-cash impairment charge of $2.4 million was recognized related to assets held for sale.
• Medicare reimbursement rates are expected to decrease by approximately 2.9% in 2025.

Risks

• Decreases in Medicare reimbursement rates may adversely affect financial results.
• Revenue received from Medicare and Medicaid is subject to potential retroactive reduction.
• The company depends upon reimbursement by third-party payors.
• The company is subject to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19).
• The company may be required to comply with put rights in certain of its acquisition agreements, related to a potential future purchase of significant equity interests in its existing subsidiaries or a separate company.
• The company's debt and financial obligations could adversely affect its financial condition, its ability to obtain future financing, and its ability to operate its business.
• The company may be adversely affected by a security breach, such as a cyber-attack, which may cause a violation of HIPAA or HITECH and subject the company to potential legal and reputational harm.

Future Outlook

The MPFS proposed by CMS for 2025 will decrease Medicare reimbursement for therapy services by approximately 2.9% as compared to the reimbursement rates in effect for most of 2024.

Industry Context

The healthcare industry, including the physical therapy business and the industrial injury prevention services business, is highly competitive. The physical therapy business as well as the industrial injury prevention services business are both highly fragmented with no company having a significant market share nationally.

Comparison to Industry Standards

• The document does not contain specific comparisons to industry standards.
• The document does not contain specific comparable companies, projects, and results.

Legal Proceedings

• The company is a party to various legal actions, proceedings, and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of its business.

Stakeholder Impact

• Shareholders will benefit from the increased dividend.
• Employees may be affected by the closure of underperforming clinics.
• Patients may experience changes in service availability due to clinic closures and acquisitions.

Next Steps

• Continue acquiring outpatient physical therapy practices.
• Develop outpatient physical therapy clinics as satellites in existing partnerships.
• Continue acquiring companies that manage outpatient physical therapy clinics or provide or serve the company's IIP sector.

Key Dates